Cognate BioServices plans $212M investment in Memphis ops

Cognate BioServices Inc. plans to renovate three Memphis properties for "cell-therapy operations, contract development, and manufacturing for drug sponsors, and related logistics" in a $212 million investment that would create 561 new jobs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.